November 2nd 2024
In children aged 12, 18, and 24 months, there was no association between maternal COVID-19 exposure and abnormal scores on a neurodevelopment screening.
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Toxic Stress Affects Children's Long-Term Health; Support Programs May Help
August 6th 2014Children who grow up in stressful settings are at higher risk of developmental problems that may later manifest as chronic disease. Fortunately, support programs may help reduce stress and improve outcomes.
Read More
FDA Expands Access to Lumizyme, Drops Risk Mitigation Requirements
August 5th 2014With its expanded approval of Lumizyme (alglucosidase alfa) to treat all Pompe disease patients, regardless of age or time of disease onset, the FDA has eliminated the Risk Evaluation and Mitigation Strategy program that restricted the drug's use to those aged 8 years or older with late-onset disease.
Read More
Codeine Still Frequently Prescribed to Kids in Emergency Department
May 5th 2014The rate of prescription of codeine to children in emergency departments for injuries and cough and upper respiratory infection remained the same from 2001 through 2010 despite guidelines recommending against its use for these conditions.
Read More